# The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

> **NCT06414395** · PHASE4 · RECRUITING · sponsor: **Theodor Bilharz Research Institute** · enrollment: 52 (estimated)

## Conditions studied

- GIT Endoscopy
- Procedural Sedation

## Interventions

- **DRUG:** Precedex (Dexmedetomidine) 200 MCG in 2 ML Injection
- **OTHER:** C group: Patients received saline infusion over 10 minutes

## Key facts

- **NCT ID:** NCT06414395
- **Lead sponsor:** Theodor Bilharz Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414395, "The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06414395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*